课题基金 / 基金详情

EFFICACY/SAFETY OF IFETROBAN AND PLACEBO IN PATIENTS WITH VENOUS LEG ULCER

EFFICACY/SAFETY OF IFETROBAN AND PLACEBO IN PATIENTS WITH VENOUS LEG ULCER
伊非曲班和安慰剂对腿部静脉溃疡患者的疗效/安全性
批准号：
6278136
负责人：
JOHN M PORTER
金额：
$2.86万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6278136
关键词：
blood vessel disorder cardiovascular disorder chemotherapy clinical research clinical trials drug screening /evaluation human subject human therapy evaluation inhibitor /antagonist longitudinal human study placebos thromboxanes ulcer

项目摘要

项目成果

JOHN M PORTER的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This randomized, double-blind, parallel group, placebo-controlled trial will test the following hypotheses in patients with venous leg ulcers: The administration of Ifetroban, a potent and highly selective thromboxane A2 (TxA2) receptor antagonist will reduce the surface area of the venous ulcer by at least 50% following 12 weeks of treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOSE RESPONSE EVALUATION OF ILOPROST IN TREATMENT OF CLAUDICATION
INTRAVENOUS AS 013 FOR TREATMENT OF SEVERE LIMB ISCHEMIA
DOSE RESPONSE EVALUATION OF ILOPROST IN TREATMENT OF CLAUDICATION
INTRAVENOUS AS 013 FOR TREATMENT OF SEVERE LIMB ISCHEMIA